| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Peter F Buckley | |
| Peter J Weiden | |||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 14-23 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications | |
| P478 | volume | 68 Suppl 6 |
| Q24678461 | A roadmap to key pharmacologic principles in using antipsychotics |
| Q26778312 | Aripiprazole: from pharmacological profile to clinical use |
| Q34498541 | Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) study |
| Q41641674 | Consumers' questions about antipsychotic medication: revealing safety concerns and the silent voices of young men. |
| Q34073723 | Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study |
| Q35191252 | Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study |
| Q34616707 | Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions |
| Q26784904 | Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders |
| Q37495004 | SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects. |
| Q36938311 | Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder |
| Q87169276 | [Adherence to psychopharmacological treatment: Psychotherapeutic strategies to enhance adherence] |
| Q50676015 | [Computer-assisted treatment pathway for schizophrenia. Development and initial experiences]. |
| Q87411640 | [Long-term treatment of schizophrenia spectrum disorders: focus on pharmacotherapy] |
Search more.